Pharmaceuticals

Inactivated Vaccines Market Growth Opportunities: Insights from 2025–2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Inactivated Vaccines Industry Compare Between 2025 And 2029?

The inactivated vaccines market has shown consistent expansion in recent years. Its value is forecast to increase from $6.19 billion in 2024 to $6.37 billion in 2025, reflecting a compound annual growth rate (CAGR) of 2.8%. Historically, this growth has been driven by factors such as polio eradication efforts, influenza vaccination programs, the emergence of infectious diseases, and various regulatory approvals.

The inactivated vaccines market size is anticipated to experience consistent expansion in the coming years. It is projected to increase to $7.58 billion by 2029, achieving a compound annual growth rate (CAGR) of 4.5%. This growth during the forecast period can be linked to factors such as pandemic preparedness, expanding vaccine coverage, biomanufacturing advancements, and health equity initiatives. Significant trends identified for the forecast period include mrna vaccine platforms, combination vaccines, thermostable vaccines, and digital vaccine passports.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13018&type=smp

Which Drivers Are Shaping The Inactivated Vaccines Industry’s Market Share?

The increasing prevalence of infectious diseases is anticipated to fuel the expansion of the inactivated vaccine market moving forward. Infectious diseases are conditions stemming from pathogens such as bacteria, viruses, fungi, or parasites, which are transmissible between individuals and can lead to a diverse range of symptoms and health complications. Tuberculosis represents a form of infectious disease. Inactivated vaccines utilize non-living pathogens to stimulate an immune response, thereby effectively preventing diseases like polio, hepatitis A and influenza. For example, in November 2023, an article published by Centers for Disease Control and Prevention, a US-based national public health agency, indicated that the number of tuberculosis patients in the USA climbed from 8,320 in 2022 to 9,615 in 2023, marking an increase of 1,295 cases. Consequently, the growing occurrence of infectious diseases is propelling the growth of the inactivated vaccine market.

How Is The Inactivated Vaccines Market Classified Into Different Segments?

The inactivated vaccines market covered in this report is segmented –

1) By Type: Viral Vaccine, Bacterial Vaccine

2) By Method Of Inactivation: Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

Subsegments:

1) By Viral Vaccine: Inactivated Poliovirus Vaccine (IPV), Inactivated Influenza Vaccine, Inactivated Hepatitis A Vaccine, Inactivated Rabies Vaccine

2) By Bacterial Vaccine: Inactivated Typhoid Vaccine, Inactivated Cholera Vaccine, Inactivated Pertussis Vaccine, Inactivated Plague Vaccine

What Trends Are Redefining The Inactivated Vaccines Market Dynamics?

Leading firms within the inactivated vaccines market are launching novel and sophisticated inactivated vaccines to maintain their competitive standing. An inactivated vaccine is comprised of cultured virus particles, bacteria, or other pathogens that have been rendered inert by killing them to eliminate their capacity to cause disease. For example, in January 2022, GSK PLC, a pharmaceutical and biotechnology firm based in the UK, introduced a novel inactivated vaccination called Shingrix to help protect against shingles (Herpes zoster). Shingrix is a recombinant subunit adjuvanted vaccine that is not live, administered via intramuscular injection in two doses. Initially, the vaccine was indicated for individuals 50 years and older. Its scope has recently broadened to include persons 18 and older who face an elevated risk of developing shingles due to immunodeficiency or immunosuppression stemming from an identified illness or medical treatment.

Who Are The Major Companies Operating In The Inactivated Vaccines Market?

Major companies operating in the inactivated vaccines market are Pfizer Inc., Johnson & Johnson Services Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., CSL Limited, Daiichi Sankyo Company Limited, Mitsubishi Tanabe Pharma Corporation, Novavax Inc., Zydus Lifesciences Ltd., Sinovac Biotech Ltd., Biological E Limited, Hualan Biological Engineering Inc., CanSino Biologics Inc., Shenzhen Kangtai Biological Products Co. Ltd., Serum Institute of India Pvt. Ltd., Beijing Tiatan Biological Products Co. Ltd., Valneva SE, Bavarian Nordic A/S., Beijing Minhai Biotechnology Co. Ltd., Bharat Biotech International Limited, Panacea Biotec Ltd., Sinergium Biotech SA, Bharat Immunologicals and Biologicals Corporation Limited, Haffkine Biopharmaceutical Corporation Limited, Incepta Vaccine Ltd., Changchun BCHT Biotechnology Co. Ltd., .

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report

What Regional Growth Trends Are Shaping The Inactivated Vaccines Market Outlook?

North America was the largest region in the inactivated vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in inactivated vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Inactivated Vaccines Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13018&type=smp

Browse Through More Reports Similar to the Global Inactivated Vaccines Market 2025, By The Business Research Company

Cancer Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

Dtp Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dtp-vaccine-global-market-report

Companion Animal Veterinary Vaccines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795